Reso 2022-3426 - Laserfiche WebLink

Home Browse Search

Governmental Entity: G13dA C, ,jN;*jISLe6 State: OO-kI>4 Authorized Official: % ( A. Address 1: IWJo Address 2: City, State, Zip: Phone: (`b6s) 7�1Z• i7 t Email: Mo pt%% . • AC The governmental entity identified above ("Governmental Entity"), in order to obtain and in consideration for the benefits provided to the Governmental Entity pursuant to the Settlement Agreement dated March 29, 2022 ("Teva Settlement"), and acting through the undersigned authorized official, hereby elects to participate in the Teva Settlement, release all Released Claims against all Releasees, and agrees as follows. 1. The Governmental Entity is aware of and has reviewed the Teva Settlement, understands that all terms in this Subdivision Settlement Participation Form have the meanings defined therein, and agrees that by signing this Subdivision Settlement Participation Form, the Govermnental Entity elects to participate in the Teva Settlement and become a Participating Subdivision as provided therein. 2. The Governmental Entity shall immediately cease any and all litigation activities as to the Releasees and Released Claims and, within the later of 7 days following the entry of the Consent Judgment or 7 days of the Execution Date of this Subdivision Settlement Participation Form voluntarily dismiss with prejudice any Released Claims that it has filed. 3. The Governmental Entity agrees to the terms of the Teva Settlement pertaining to Subdivisions as defined therein. 4. By agreeing to the terms of the Teva Settlement and expressly agreeing to the releases provided for therein, the Governmental Entity is entitled to the benefits provided therein, including, if applicable, monetary payments beginning after the Effective Date of the Agreement. 5. The Governmental Entity agrees to use any monies it receives through the Teva Settlement solely for the purposes provided therein. 6. The Governmental Entity submits to the jurisdiction of the Court for purposes limited to the Court's role as provided in, and for resolving disputes to the extent provided in, the Teva Settlement.